A Global Survey of Physicians Knowledge About Non-alcoholic Fatty Liver Disease.
暂无分享,去创建一个
M. Buti | M. Zheng | M. Stepanova | Y. Eguchi | A. Duseja | L. Henry | Z. Younossi | M. Diago | M. Romero-Gómez | J. George | E. Bugianesi | Ming‐Lung Yu | Y. Yılmaz | M. Arrese | P. Burra | L. Castéra | N. Méndez-Sánchez | Jian-Gao Fan | W. Chan | G. Papatheodoridis | M. El kassas | S. Alqahtani | A. Racila | H. Saeed | J. Ong | B. Lam | K. Alswat | M. Kugelmas | Vincent Wai-Sun Wong | Hirokazu Takahashi | I. Younossi | M. Ziayee | M. Romero‐Gomez | M. Yu | Vincent Wai‐Sun Wong | Yuichiro Eguchi | Ming‐Lung Yu
[1] R. Biswas,et al. Poor Awareness of Liver Disease Among Adults With NAFLD in the United States , 2021, Hepatology communications.
[2] M. Stepanova,et al. Health-related quality of life in Cuban patients with chronic liver disease: a real-world experience. , 2020, Annals of hepatology.
[3] Su-Jau Yang,et al. The Natural History of NAFLD, a Community‐Based Study at a Large Health Care Delivery System in the United States , 2020, Hepatology communications.
[4] V. Wong,et al. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease , 2020, Hepatology International.
[5] K. Trees,et al. Providing Care for Fatty Liver Disease Patients , 2020, Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates.
[6] Z. Goodman,et al. From NAFLD to MAFLD: Implications of a Premature Change in Terminology , 2020, Hepatology.
[7] V. Wong,et al. A new definition for metabolic associated fatty liver disease: an international expert consensus statement. , 2020, Journal of hepatology.
[8] Z. Younossi,et al. Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD , 2020, Hepatology.
[9] V. Wong,et al. Reduced Patient-Reported Outcome Scores Associate with Level of Fibrosis in Patients with Nonalcoholic Steatohepatitis. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[10] A. Mangia,et al. Patients With Nonalcoholic Steatohepatitis Experience Severe Impairment of Health-Related Quality of Life. , 2019, The American journal of gastroenterology.
[11] F. Tacke,et al. Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis , 2019, Hepatology.
[12] M. Rinella,et al. Nonalcoholic Fatty Liver Disease: Identification and Management of High-Risk Patients. , 2019, The American journal of gastroenterology.
[13] Z. Younossi. Non-alcoholic fatty liver disease - A global public health perspective. , 2019, Journal of hepatology.
[14] 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2019 , 2018, Diabetes Care.
[15] N. Sattar,et al. Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease , 2018, BMC Medicine.
[16] S. Seneviratne,et al. Survey on knowledge of non-alcoholic fatty liver disease (NAFLD) among doctors in Sri Lanka: a multicenter study , 2018, BMC Research Notes.
[17] K. Irvine,et al. Underappreciation of non‐alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis , 2018, Internal medicine journal.
[18] Michael Charlton,et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases , 2018, Hepatology.
[19] L. Henry,et al. Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.
[20] H. Tilg,et al. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. , 2016, Journal of hepatology.
[21] M. Stuntz,et al. Awareness of nonalcoholic steatohepatitis and associated practice patterns of primary care physicians and specialists , 2016, BMC Research Notes.
[22] Aijaz Ahmed,et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. , 2015, Gastroenterology.
[23] Marjory L. Givens,et al. Primary care practitioners survey of non-alcoholic fatty liver disease. , 2013, Annals of hepatology.
[24] C. Renou,et al. A survey of patterns of practice and perception of NAFLD in a large sample of practicing gastroenterologists in France. , 2012, Journal of hepatology.
[25] H. Kim,et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[26] Anna Castiglione,et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population , 2006, BMC gastroenterology.
[27] L. Henry,et al. NAFLD AND NASH: Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention , 2018 .